Prot #AG120-C-005: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled Study of AG-120 in Previously-treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

Project: Research project

Project Details

StatusFinished
Effective start/end date1/25/18 → 1/25/21

Funding

  • DrugDev Inc. (Prot #AG120-C-005 // Prot #AG120-C-005)
  • Agios Pharmaceuticals, Inc. (Prot #AG120-C-005 // Prot #AG120-C-005)